ClinicalTrials.gg
RecruitingNCT06257095Updated Jun 3, 2026

Improving Adult Protective Services Client Outcomes: A Stepped-Care Social and Mental Health Engagement Program

An interventional study of Stepped-care social and mental health engagement and APS Usual care in Depression in Old Age, sponsored by The University of Texas Health Science Center, Houston. Recruiting at 1 site in United States. Open to participants aged 65 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-06-03.

Sponsored by The University of Texas Health Science Center, Houston · Not applicable, Interventional, and Supportive care

How we know

From the registry’s dates

  • Registered 5 months after the study started (first participant enrolled Aug 2023, registered Feb 2024).
  • Started Aug 2023; still recruiting 3 years 3 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
400
Allocation
Randomized
Ages
65 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 16 studies in Depression by The University of Texas Health Science Center, Houston — 4 open to participants now, 6 under way, none of them phase 3. Depression · The University of Texas Health Science Center, Houston.

Planned enrollment
Largest of 15
400 · median 29
Started
2023
with 1 other
No phase
14 of 16
4 open now
Registered
13th of 16
by date

Among the 16 studies in Depression by The University of Texas Health Science Center, Houston, this one has the largest planned enrollment of the 15 interventional ones that give a count, is one of 2 that started in 2023, is one of 14 with no phase, and was the 13th registered.

Depression

8,608 studies on the registry are indexed under Depression; 1,736 are open to participants now.

Browse Depression studies →

Open to participants now

4 of the 16 studies in Depression by The University of Texas Health Science Center, Houston are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 4 open studies →

Where they have run

Who these studies take

Of the 1,098 Depression studies recruiting now, 475 (43%) set no upper age limit and 522 (48%) stop at 75 or younger; 205 take children under 18; 315 take healthy volunteers.

This study: 65 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 16 studies in Depression by The University of Texas Health Science Center, Houston, or all of them as a file.
02

Study summary

The purpose of this study is to ascertain the feasibility and effectiveness of an 8-week social engagement program aimed at reducing depression and increasing social engagement among seniors who are transitioning out of Adult Protective Services (APS) for either elder abuse or self-neglect.

03

Conditions studied

  • Depression in Old Age

Browse trials for

Keywords

  • social engagement
  • Adult Protective Services (APS)
  • elder abuse
  • self neglect
04

Who can participate

Ages eligible
65 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Older Adults

  • an APS validated EM/SN case
  • able to provide
  • able to speaks English or Spanish
  • able to hear sufficiently using the telephone
  • transitioning out of APS intervention (i.e. in the case closure phase of the APS service).

Student

  • college or university student
  • enrolled in a health-related program
  • commit to making 8-weekly consecutive calls
  • complete the required 1-hour training and assessment.

Exclusion criteria

Exclusion Criteria:

Older Adults

  • Individuals needing a proxy to consent
  • suspected or confirmed decision-making capacity impairments or uncontrolled psychiatric illnesses such as schizophrenia, paranoia, delusion, or delirium

Student

-only engaging in the program to fulfill some educational requirement

Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
400 participants (estimated)

Study arms

  • Experimental
    Treatment

    Behavioral: Stepped-care social and mental health engagement · Behavioral: APS Usual care

  • Active comparator
    Usual Care

    Behavioral: APS Usual care

Interventions

  • BehavioralStepped-care social and mental health engagement

    Each student will be matched to an older adult and the students will make one call o the older adult which lasts upto 1 hour each week for 8 weeks. Ending each call, the student will assess symptoms of depression anxiety through questionnaires. If the participant responds yes on two consecutive calls to any of these questions, they will be asked if they would like to receive a call from the University of Texas Health Science Center Trauma and Resilience Center to discuss free counseling services.

  • BehavioralAPS Usual care

    Participants will receive a phone call for data collection. Then they will be offered to receive an abbreviated version of the stepped-care social and mental health engagement intervention, lasting only 6-weeks with the option to continue calls if agreeable between the student and older adult.

06

What researchers measure

Primary outcomes

  1. Change in social isolation assessed by the Duke Social Support Index (DSSI-6)

    This is a 6-item questionnaire and each is measured from 1(hardly ever) to 3(most of the time) for a maximum score of 18, higher score indicating greater social support

    Time frame: baseline, 4-week and 8-week follow-up

  2. Change in loneliness as assessed by the University of California Los Angeles (UCLA )loneliness scale

    This is a 20-item questionnaire , each item is rated as either O ("I often feel this way"), S ("I sometimes feel this way"), R ("I rarely feel this way"), N ("I never feel this way") for a score range of 0-3,for a maximum score of 60, higher score indicating worse outcome

    Time frame: baseline, 4-week and 8-week follow-up

  3. Change in depression as assessed by the PATIENT HEALTH QUESTIONNAIRE (PHQ-9)

    This is a 9 item questionnaire and each is scored from 0(not at all) to 3(nearly every day) , for a maximum score of 27 , higher score indicating more depression

    Time frame: baseline, 4-week and 8-week follow-up

  4. Recurrence of Elder mistreatment (EM)

    This is a yes or no questionnaire that will be answered by adult protective services (APS)

    Time frame: From participant's first call to 1 month post final call

  5. Recurrence of self neglect (SN)

    This is a yes or no questionnaire that will be answered by adult protective services (APS)

    Time frame: From participant's first call to 1 month post final call

Secondary outcomes

  1. Change in anxiety as assessed by the Generalized Anxiety Disorder scale (GAD-7)

    This is a 7-item questionnaire , each is scored from 0(not at all) to 3(nearly every day), for a score range of 0-21 higher score indicating more anxiety

    Time frame: baseline, 4-week and 8-week follow-up

  2. Change in resilience as assessed by the Brief Resilience Scale

    This is a 6-item questionnaire, questions 1, and 5 are scored from 1(strongly disagree) to 5(strongly agree) and questions 2, 4 and 6 are reverse scored , for a score range of 6-30. The total score is then divided by the number of questions answered to get the final score. higher score indicating more resilience.

    Time frame: baseline, 4-week and 8-week follow-up

  3. Change in Anxiety as Assessed by the Generalized Anxiety Disorder 2-Item Scale (GAD-2)

    This is a 2 item questionnaire and each is scored from 0(not at all) to 3( nearly every day).Total scores range from 0 to 6, with higher scores indicating greater anxiety symptom severity. A score of ≥3 is considered a positive screen for clinically significant anxiety.

    Time frame: baseline, 4-week and 8-week follow-up

  4. Change in Depressive Symptoms as Assessed by the Patient Health Questionnaire-2 (PHQ-2)

    This is a 2 item questionnaire and each is scored from 0(not at all) to 3(nearly every day) for a total score range of 0-6,higher scores indicate greater depressive symptom severity

    Time frame: baseline, 4-week and 8-week follow-up

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Aug 2023 (actual). Primary completion is estimated for Oct 2026, 38 months after the start.

Of 3,486 non-industry interventional studies with no phase under Depression, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 41. This study's planned 38 months is above that.

Counting every sponsor, half of 3,584 studies reached it within 21 months; a quarter within 9 and three quarters within 41.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 5, 2024
First posted
Feb 13, 2024
StartActual
Aug 9, 2023
Primary completionEst.
Oct 31, 2026
CompletionEst.
Oct 31, 2026
Last update
Jun 3, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 3, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06257095
Collaborators
Department of Health and Human Services
Responsible party
Jason Burnett (Associate Professor, The University of Texas Health Science Center, Houston) — Principal investigator
First posted
Feb 13, 2024
Start date
Aug 9, 2023
Primary completion
Oct 31, 2026 (estimated)
Completion
Oct 31, 2026 (estimated)
Last update
Jun 3, 2026

Study contacts

Jason Burnett, PhD
Contact
Jason.Burnett@uth.tmc.edu
(713) 873-4685
Jordan Broussard, MS
Contact
Jordan.Broussard@uth.tmc.edu
713 500 0321
Jason Burnett, PhD
principal investigator · The University of Texas Health Science Center, Houston

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion